Latest News

Fluorescent compounds allow clinicians to visualize Alzheimer's disease as it progresses

What if doctors could visualize all of the processes that take place in the brain during the development and progression of Alzheimer's disease? Such a window would provide a powerful aid for diagnosing the condition. Now, researchers have developed a new class of imaging agents that enables them to visualize tau protein aggregates, a pathological hallmark of Alzheimer's disease and related neurodegenerative disorders, directly in the brains of living patients.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Emergency aid for overdoses

  • Improving bladder function among people with spinal cord injuries

  • Blinded by non-science: Trivial scientific information increases trust in products

  • Pathological gambling is associated with altered opioid system in the brain

  • Highly connected CEOs more likely to broker mergers and acquisitions that harm firms, study shows

  • Heart rate may predict survival, brain function in comatose cardiac arrest survivors

  • Cold sores increase risk of dementia, research suggests

  • User-friendly electronic 'Eyecane' enhances navigational abilities for blind

  • Design of micro, nanoparticles to improve treatments for Alzheimer's, Parkinson's

  • Sexual preference for masculine men, feminine women is an urban habit

  •